BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04165096-completion@plaintrial.com
DTSTAMP:20261029T024431Z
DTSTART;VALUE=DATE:20250528
SUMMARY:KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab
  (MK-3475) When Used With Investigational Agents in Participants With Adva
 nced Non-small Cell Lung Cancer (NSCLC)\, Previously Treated With Anti-pro
 grammed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER
 -U01C) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04165096
URL:https://plaintrial.com/trial/NCT04165096
END:VEVENT
END:VCALENDAR